NNNNAnbio Biotechnology
Slide 1 of 3
Company Overview
Name
Anbio Biotechnology
52W High
$44.73
52W Low
$4.16
Market Cap
$670.5M
Dividend Yield
0%
Price/earnings
0.147
P/E
0.147
Dividends
No dividend
Sentiment
Score
Bullish
68
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$8.6M
Operating Revenue
$8.6M
Total Gross Profit
$7.5M
Total Operating Income
$5.8M
Net Income
$6.4M
EV to EBITDA
$105.19
EV to Revenue
$76.17
Price to Book value
$22.24
Price to Earnings
$104.71
Additional Data
Selling, General & Admin Expense
$1.6M
Research & Development Expense
$201.3K
Total Operating Expenses
$-1.8M
Interest & Investment Income
$142K
Other Income / (Expense), net
$493.7K
Total Other Income / (Expense), net
$635.7K
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Anbio Biotechnology
52W High
$44.73
52W Low
$4.16
Market Cap
$670.5M
Dividend Yield
0%
Price/earnings
0.147
P/E
0.147
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Bullish
68
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$8.6M
Operating Revenue
$8.6M
Total Gross Profit
$7.5M
Total Operating Income
$5.8M
Net Income
$6.4M
EV to EBITDA
$105.19
EV to Revenue
$76.17
Price to Book value
$22.24
Price to Earnings
$104.71
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$1.6M
Research & Development Expense
$201.3K
Total Operating Expenses
$-1.8M
Interest & Investment Income
$142K
Other Income / (Expense), net
$493.7K
Total Other Income / (Expense), net
$635.7K
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Michael Lau
Location
N/A, Germany
Exchange
Nasdaq
Summary
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products.
Company Info
CEO
Michael Lau
Location
N/A, Germany
Exchange
Nasdaq
Summary
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products.
AI Insights
Be the first to know. We'll notify you when AI insights for NNNN go live.
Community Research
Research from investors like you
Be the first to share your analysis on NNNN
Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.
Topics: Company overview • Products • Competitors • Strengths & Risks
Symbol's posts
No more topics to show